Protenus Named to the 2019 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
Protenus recognized for achievements in healthcare compliance analytics
New York, NY, October 2, 2019 -- CB Insights today named Protenus to the inaugural Digital Health 150 ranking, showcasing the 150 most promising private digital health companies in the world. CB Insights CEO Anand Sanwal revealed the final Digital Health 150 during Future of Health, a gathering of top executives across some of the largest healthcare institutions, startups, and investment firms.
“From pharmaceuticals to patient care, technology is rapidly changing healthcare, and The Digital Health 150 showcases the 150 best startups spearheading innovation and change in the sector,” said CB Insights CEO Anand Sanwal. “It's a privilege to use CB Insights' data to identify and shine a light on these companies, and we look forward to tracking their success in 2019 and beyond."
The Digital Health 150 companies span the globe, from Canada, China, Germany, Israel, the United States, and the United Kingdom, and are supported by more than 360 investors.
“We are seeing rapid adoption of healthcare compliance analytics across the U.S., delivering impactful results to our customers and helping set a higher standard when it comes to protecting patients and their data,” stated Nick Culbertson, Protenus CEO and Co-Founder. “We owe our success to the innovative health systems who have partnered with our team, including the majority of the U.S.’s top hospitals, and share our vision and passion for innovating healthcare. We are excited for what lies ahead in 2020.”
Through an evidence-based approach, the CB Insights research team selected the Digital Health 150 from hundreds of applications based on several factors including patent activity, investor quality, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength, and tech novelty. The Mosaic Score, based on CB Insights’ algorithm, measures the overall health and growth potential of private companies to help predict a company’s momentum.
Founded in 2014, Protenus helps health systems leverage healthcare compliance analytics to demonstrate 100% compliance and proactively identify risk across the organization such as inappropriate access to patient data and the theft and misuse of controlled substances by hospital staff. Protenus was ranked as a top solution in patient privacy monitoring by Black Book and KLAS Research. Protenus was also named a Gartner “Cool Vendor” in Healthcare Artificial Intelligence and received the Innovation of the Year in Data Security award by Healthcare Informatics. Protenus was recognized as one of the Best Places to Work in Healthcare by Modern Healthcare in 2018 and 2019, and its co-founders, Nick Culbertson & Robert Lord, were finalists for the 2019 EY Entrepreneur of the Year Award, Mid-Atlantic region.
Quick facts on the 2019 Digital Health 150:
In 2018, these emerging private companies cumulatively raised $5.7B across 117 deals. They're on track to surpass these numbers in 2019, with $3B raised across 73 deals as of Q2'19.
A total of 17 companies have reached a unicorn valuation of $1B or more. GRAIL, Oscar Health, and We Doctor round out the top three most funded companies on the list.
Over 75% of the Digital Health 150 are headquartered outside the United States, including 17 from Asia and 17 from Europe
Over 850 unique investors have funded the Digital Health 150, with F-Prime Capital, New Enterprise Associates, and Google Ventures taking the top three spots as the most active investors.
About CB Insights At CB Insights, we believe the most complex strategic business questions are best answered with facts. We are a machine intelligence company that synthesizes, analyzes and visualizes millions of documents to give our clients fast, fact-based insights. Serving the majority of the Fortune 100, we give companies the power to make better decisions, take control of their own future, and capitalize on change.
Hyeri Kim, Senior Manager - PR & Communications
+1 212-292-3148 ext. 3020